Nuclear Medicine and Radiopharmaceutic Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Nuclear Medicine and Radiopharmaceutic market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Nuclear Medicine and Radiopharmaceutic market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Nuclear Medicine and Radiopharmaceutic market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Nuclear Medicine and Radiopharmaceutic market segmented into
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
- Oncology
- Cardiology
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Company
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NUCLEAR MEDICINE AND RADIOPHARMACEUTIC INDUSTRY
2.1 Summary about Nuclear Medicine and Radiopharmaceutic Industry
2.2 Nuclear Medicine and Radiopharmaceutic Market Trends
2.2.1 Nuclear Medicine and Radiopharmaceutic Production & Consumption Trends
2.2.2 Nuclear Medicine and Radiopharmaceutic Demand Structure Trends
2.3 Nuclear Medicine and Radiopharmaceutic Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Diagnostic Radioisotopes
4.2.2 Therapeutic Radioisotopes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oncology
4.3.2 Cardiology
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Diagnostic Radioisotopes
5.2.2 Therapeutic Radioisotopes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oncology
5.3.2 Cardiology
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Diagnostic Radioisotopes
6.2.2 Therapeutic Radioisotopes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oncology
6.3.2 Cardiology
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Diagnostic Radioisotopes
7.2.2 Therapeutic Radioisotopes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oncology
7.3.2 Cardiology
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Diagnostic Radioisotopes
8.2.2 Therapeutic Radioisotopes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oncology
8.3.2 Cardiology
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Diagnostic Radioisotopes
9.2.2 Therapeutic Radioisotopes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oncology
9.3.2 Cardiology
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Company
10.1.2 Bracco Imaging
10.1.3 Bayer
10.1.4 Mallinckrodt
10.1.5 Nordion
10.1.6 Triad Isotopes
10.1.7 Lantheus
10.1.8 IBA Group
10.1.9 GE Healthcare
10.1.10 China Isotope & Radiation
10.1.11 Jubilant Pharma
10.1.12 Eli Lilly
10.1.13 Advanced Accelerator Applications
10.1.14 SIEMENS
10.1.15 Dongcheng
10.1.16 Navidea
10.2 Nuclear Medicine and Radiopharmaceutic Sales Date of Major Players (2017-2020e)
10.2.1 Company
10.2.2 Bracco Imaging
10.2.3 Bayer
10.2.4 Mallinckrodt
10.2.5 Nordion
10.2.6 Triad Isotopes
10.2.7 Lantheus
10.2.8 IBA Group
10.2.9 GE Healthcare
10.2.10 China Isotope & Radiation
10.2.11 Jubilant Pharma
10.2.12 Eli Lilly
10.2.13 Advanced Accelerator Applications
10.2.14 SIEMENS
10.2.15 Dongcheng
10.2.16 Navidea
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NUCLEAR MEDICINE AND RADIOPHARMACEUTIC INDUSTRY
2.1 Summary about Nuclear Medicine and Radiopharmaceutic Industry
2.2 Nuclear Medicine and Radiopharmaceutic Market Trends
2.2.1 Nuclear Medicine and Radiopharmaceutic Production & Consumption Trends
2.2.2 Nuclear Medicine and Radiopharmaceutic Demand Structure Trends
2.3 Nuclear Medicine and Radiopharmaceutic Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Diagnostic Radioisotopes
4.2.2 Therapeutic Radioisotopes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oncology
4.3.2 Cardiology
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Diagnostic Radioisotopes
5.2.2 Therapeutic Radioisotopes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oncology
5.3.2 Cardiology
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Diagnostic Radioisotopes
6.2.2 Therapeutic Radioisotopes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oncology
6.3.2 Cardiology
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Diagnostic Radioisotopes
7.2.2 Therapeutic Radioisotopes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oncology
7.3.2 Cardiology
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Diagnostic Radioisotopes
8.2.2 Therapeutic Radioisotopes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oncology
8.3.2 Cardiology
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Diagnostic Radioisotopes
9.2.2 Therapeutic Radioisotopes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oncology
9.3.2 Cardiology
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Company
10.1.2 Bracco Imaging
10.1.3 Bayer
10.1.4 Mallinckrodt
10.1.5 Nordion
10.1.6 Triad Isotopes
10.1.7 Lantheus
10.1.8 IBA Group
10.1.9 GE Healthcare
10.1.10 China Isotope & Radiation
10.1.11 Jubilant Pharma
10.1.12 Eli Lilly
10.1.13 Advanced Accelerator Applications
10.1.14 SIEMENS
10.1.15 Dongcheng
10.1.16 Navidea
10.2 Nuclear Medicine and Radiopharmaceutic Sales Date of Major Players (2017-2020e)
10.2.1 Company
10.2.2 Bracco Imaging
10.2.3 Bayer
10.2.4 Mallinckrodt
10.2.5 Nordion
10.2.6 Triad Isotopes
10.2.7 Lantheus
10.2.8 IBA Group
10.2.9 GE Healthcare
10.2.10 China Isotope & Radiation
10.2.11 Jubilant Pharma
10.2.12 Eli Lilly
10.2.13 Advanced Accelerator Applications
10.2.14 SIEMENS
10.2.15 Dongcheng
10.2.16 Navidea
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Nuclear Medicine and Radiopharmaceutic Product Type Overview
Table Nuclear Medicine and Radiopharmaceutic Product Type Market Share List
Table Nuclear Medicine and Radiopharmaceutic Product Type of Major Players
Table Brief Introduction of Company
Table Brief Introduction of Bracco Imaging
Table Brief Introduction of Bayer
Table Brief Introduction of Mallinckrodt
Table Brief Introduction of Nordion
Table Brief Introduction of Triad Isotopes
Table Brief Introduction of Lantheus
Table Brief Introduction of IBA Group
Table Brief Introduction of GE Healthcare
Table Brief Introduction of China Isotope & Radiation
Table Brief Introduction of Jubilant Pharma
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Advanced Accelerator Applications
Table Brief Introduction of SIEMENS
Table Brief Introduction of Dongcheng
Table Brief Introduction of Navidea
Table Products & Services of Company
Table Products & Services of Bracco Imaging
Table Products & Services of Bayer
Table Products & Services of Mallinckrodt
Table Products & Services of Nordion
Table Products & Services of Triad Isotopes
Table Products & Services of Lantheus
Table Products & Services of IBA Group
Table Products & Services of GE Healthcare
Table Products & Services of China Isotope & Radiation
Table Products & Services of Jubilant Pharma
Table Products & Services of Eli Lilly
Table Products & Services of Advanced Accelerator Applications
Table Products & Services of SIEMENS
Table Products & Services of Dongcheng
Table Products & Services of Navidea
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) by Region 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) Share by Demand 2021f-2026f
Table Nuclear Medicine and Radiopharmaceutic Product Type Overview
Table Nuclear Medicine and Radiopharmaceutic Product Type Market Share List
Table Nuclear Medicine and Radiopharmaceutic Product Type of Major Players
Table Brief Introduction of Company
Table Brief Introduction of Bracco Imaging
Table Brief Introduction of Bayer
Table Brief Introduction of Mallinckrodt
Table Brief Introduction of Nordion
Table Brief Introduction of Triad Isotopes
Table Brief Introduction of Lantheus
Table Brief Introduction of IBA Group
Table Brief Introduction of GE Healthcare
Table Brief Introduction of China Isotope & Radiation
Table Brief Introduction of Jubilant Pharma
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Advanced Accelerator Applications
Table Brief Introduction of SIEMENS
Table Brief Introduction of Dongcheng
Table Brief Introduction of Navidea
Table Products & Services of Company
Table Products & Services of Bracco Imaging
Table Products & Services of Bayer
Table Products & Services of Mallinckrodt
Table Products & Services of Nordion
Table Products & Services of Triad Isotopes
Table Products & Services of Lantheus
Table Products & Services of IBA Group
Table Products & Services of GE Healthcare
Table Products & Services of China Isotope & Radiation
Table Products & Services of Jubilant Pharma
Table Products & Services of Eli Lilly
Table Products & Services of Advanced Accelerator Applications
Table Products & Services of SIEMENS
Table Products & Services of Dongcheng
Table Products & Services of Navidea
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) by Region 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Nuclear Medicine and Radiopharmaceutic Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Company 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Bracco Imaging 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Mallinckrodt 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Nordion 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Triad Isotopes 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Lantheus 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of IBA Group 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of GE Healthcare 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of China Isotope & Radiation 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Jubilant Pharma 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Advanced Accelerator Applications 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of SIEMENS 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Dongcheng 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Navidea 2017-2020e
Figure Global Nuclear Medicine and Radiopharmaceutic Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nuclear Medicine and Radiopharmaceutic Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Company 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Bracco Imaging 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Mallinckrodt 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Nordion 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Triad Isotopes 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Lantheus 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of IBA Group 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of GE Healthcare 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of China Isotope & Radiation 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Jubilant Pharma 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Advanced Accelerator Applications 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of SIEMENS 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Dongcheng 2017-2020e
Figure Nuclear Medicine and Radiopharmaceutic Sales Revenue (Million USD) of Navidea 2017-2020e
